2020 IPO

Compass Pathways Stock

Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.

Sign up today and learn more about Compass Pathways Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Compass Pathways Stock

Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.

Funding History

January 2017$4.0M

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo